GlassScriptPhysician profile
Pei-Hsiu Huang
NPI 1992901573
$113,632.49
in general payments reported to CMS, 2019-2025
18 companies · $11K in 2025
The $11K reported for 2025 was more than what 90% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,344 · 2020: $27K · 2021: $13K · 2022: $17K · 2023: $16K · 2024: $22K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $26K · Travel and Lodging: $13K · Food and Beverage: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,625.00 |
| Travel and Lodging | $13,056.52 |
| Food and Beverage | $10,651.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $85,090.18 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Medtronic, INC. | $17,881.28 | 2021-2025 | Harmony, Corevalve Evolut R, Melody Tpv |
| Abbott Laboratories | $7,551.86 | 2019-2025 | Mitraclip, Triclip, Amplatzer Amulet |
| Siemens Medical Solutions USA, INC. | $883.23 | 2021 | |
| Abiomed | $636.51 | 2021-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $563.24 | 2021-2025 | Lifevest |
| Inari Medical, INC. | $260.42 | 2022 | |
| Boston Scientific Corporation | $212.50 | 2019-2023 | Watchman Flx |
| Recor Medical INC | $147.21 | 2024 | Paradise Renal Denervation System |
| Pfizer INC. | $88.76 | 2024 | |
| W. L. Gore & Associates, INC. | $82.00 | 2024 | Gore Cardioform Septal Occluder |
| Medtronic Vascular, INC. | $54.64 | 2019 | |
| Philips North America LLC | $54.06 | 2024-2025 | Igt Devices Undivided, (Bq9) Coronary Ivus |
| Cardiva Medical, INC. | $47.70 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Stryker Corporation | $25.48 | 2025 | Flowtriever |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acutus Medical, INC. | $20.00 | 2020 | |
| B. Braun Interventional Systems INC. | $19.73 | 2025 | Cp Stent |
| Bard Peripheral Vascular, INC. | $13.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pei-Hsiu Huang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.